Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial
Ayal A. Aizer(Brigham and Women's Hospital), Rifaquat Rahman(Brigham and Women's Hospital), Lauren Hertan(University of Pennsylvania), Patrick Y. Wen(Dana-Farber Cancer Institute), Jack M. Qian(South Shore Hospital), Diana D. Shi(Harvard University), R. Shiloh(Brigham and Women's Hospital), Daniel Cagney(Mater Misericordiae University Hospital), Marciana Johnson(Brigham and Women's Hospital), Jacob Sands(Harvard University), Raymond H. Mak(Twitter (United States)), Paul D. Brown(Mayo Clinic), Paul J. Catalano(Computational Physics (United States)), David Kozono(Brigham and Women's Hospital), Itai Pashtan(Brigham and Women's Hospital), Fallon Chipidza(Brigham and Women's Hospital), Daphne A. Haas‐Kogan(Brigham and Women's Hospital), Luke Peng(Dana-Farber Brigham Cancer Center), Monica Krishnan(Brigham and Women's Hospital), Ivy Ricca(Brigham and Women's Hospital), Shyam Tanguturi(Harvard University), Grant Benham(Brigham and Women's Hospital), Kee‐Young Shin(Dana-Farber Cancer Institute)
Cited by 19
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k